What ‘Modicare’ May Mean (Or Not) For Pharma In India

Ambitious and complex to say the least, India’s “Modicare” – the proposed National Health Protection Scheme – could have significant implications on market expansion in the country. Scrip brings you an early take from pharma industry experts on what to expect (or not) and where the key challenges lie.